CDC- BRFSS – ACBS 2022 Adult Prevalence Table 7
State/Territory | Current | |||
---|---|---|---|---|
Sample size± |
% | SE§ | 95% CI† | |
Arizona | 328 | 23.0 | 3.7 | (15.7 – 30.3) |
California | 307 | 21.5 | 3.2 | (15.2 – 27.8) |
Connecticut | 490 | 34.4 | 3.2 | (28.1 – 40.7) |
Florida | 449 | 26.0 | 4.2 | (17.8 – 34.2) |
Georgia | 329 | 33.6 | 4.5 | (24.8 – 42.4) |
Hawaii | 204 | 27.4 | 5.0 | (17.6 – 37.2) |
Indiana | 474 | 28.2 | 2.6 | (23.1 – 33.3) |
Iowa | 287 | 35.3 | 3.8 | (27.9 – 42.7) |
Kansas | 233 | 29.3 | 4.2 | (21.1 – 37.5) |
Maine | 351 | 28.4 | 3.8 | (21.0 – 35.8) |
Maryland | 387 | 32.1 | 3.8 | (24.7 – 39.5) |
Massachusetts | 328 | 34.9 | 3.8 | (27.5 – 42.3) |
Michigan | 502 | 29.3 | 2.6 | (24.2 – 34.4) |
Minnesota | 539 | 30.5 | 2.8 | (25.0 – 36.0) |
Missouri | 237 | 30.3 | 4.2 | (22.1 – 38.5) |
Nebraska | 158 | 26.3 | 4.6 | (17.3 – 35.3) |
New Hampshire | 379 | 29.2 | 3.3 | (22.7 – 35.7) |
New Jersey | 296 | 37.6 | 3.8 | (30.2 – 45.0) |
New Mexico | 158 | 30.9 | 5.3 | (20.5 – 41.3) |
New York | 314 | 29.2 | 3.4 | (22.5 – 35.9) |
Ohio | 405 | 26.3 | 3.2 | (20.0 – 32.6) |
Oregon | 139 | 22.5 | 4.8 | (13.1 – 31.9) |
Rhode Island | 237 | 37.6 | 4.2 | (29.4 – 45.8) |
Texas | 279 | 23.6 | 3.8 | (16.2 – 31.0) |
Utah | 308 | 29.2 | 3.5 | (22.3 – 36.1) |
Vermont | 498 | 31.6 | 2.6 | (26.5 – 36.7) |
Wisconsin | 395 | 30.2 | 3.0 | (24.3 – 36.1) |
Puerto Rico | 260 | 21.0 | 3.4 | (14.3 – 27.7) |
28 States / Area | 9,271 | 27.8 | 1.0 | (25.8 – 29.8) |
Median | 29.3 | |||
Range | 21.0-37.6 |
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2022/pdf/sdq_report_acbs_22-508.pdf